These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33176316)

  • 21. The ASCOD Phenotyping of Embolic Strokes of Undetermined Source.
    Shimizu T; Kashima S; Akiyama H; Isahaya K; Hasegawa Y
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104491. PubMed ID: 31761736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary Stroke Prevention Following Embolic Stroke of Unknown Source in the Absence of Documented Atrial Fibrillation: A Clinical Review.
    Kotadia ID; Sim I; Mukherjee R; O'Hare D; Chiribiri A; Birns J; Bhalla A; O'Neill M; Williams SE
    J Am Heart Assoc; 2021 Jul; 10(13):e021045. PubMed ID: 34212774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of Finding Embolic Sources for Patients with Embolic Stroke of Undetermined Source.
    Umemura T; Nishizawa S; Nakano Y; Saito T; Kitagawa T; Miyaoka R; Suzuki K; Yamamoto J
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1810-1815. PubMed ID: 31097326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of recurrent ischemic stroke in young cryptogenic patients with embolic stroke of undetermined source.
    Šaňák D; Divišová P; Hutyra M; Král M; Bártková A; Zapletalová J; Látal J; Dorňák T; Hudec Š; Franc D; Polidar P; Veverka T; Kaňovský P
    J Neurol Sci; 2020 Sep; 416():116985. PubMed ID: 32563078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial.
    Del Brutto VJ; Diener HC; Easton JD; Granger CB; Cronin L; Kleine E; Grauer C; Brueckmann M; Toyoda K; Schellinger PD; Lyrer P; Molina CA; Chutinet A; Bladin CF; Estol CJ; Sacco RL
    J Am Heart Assoc; 2022 Jun; 11(11):e023545. PubMed ID: 35656979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent Stroke Incidence and Etiology in Patients with Embolic Stroke of Undetermined Source and Other Stroke Subtypes.
    Toi S; Shirai Y; Ishizuka K; Hosoya M; Seki M; Higuchi E; Hoshino T; Kitagawa K
    J Atheroscler Thromb; 2022 Mar; 29(3):393-402. PubMed ID: 33597329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke.
    Tanaka K; Koga M; Lee KJ; Kim BJ; Park EL; Lee J; Mizoguchi T; Yoshimura S; Cha JK; Lee BC; Nakahara J; Suzuki N; Bae HJ; Toyoda K;
    Stroke; 2020 Apr; 51(4):1150-1157. PubMed ID: 32098607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age- and sex-specific analysis of patients with embolic stroke of undetermined source.
    Ntaios G; Lip GYH; Vemmos K; Koroboki E; Manios E; Vemmou A; Rodríguez-Campello A; Cuadrado-Godia E; Roquer J; Arnao V; Caso V; Paciaroni M; Diez-Tejedor E; Fuentes B; Pérez Lucas J; Arauz A; Ameriso SF; Pertierra L; Gómez-Schneider M; Hawkes MA; Bandini F; Chavarria Cano B; Iglesias Mohedano AM; García Pastor A; Gil-Núñez A; Putaala J; Tatlisumak T; Barboza MA; Athanasakis G; Gioulekas F; Makaritsis K; Papavasileiou V
    Neurology; 2017 Aug; 89(6):532-539. PubMed ID: 28687720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
    Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG;
    Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.
    Hellwig S; Grittner U; Herm J; Ruschmann R; Konieczny M; Endres M; Haeusler KG
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105266. PubMed ID: 32992191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dabigatran vs. Aspirin for Secondary Prevention After Embolic Stroke of Undetermined Source　- Japanese Subanalysis of the RE-SPECT ESUS Randomized Controlled Trial.
    Toyoda K; Uchiyama S; Hagihara Y; Kuwashiro T; Mori T; Kamiyama K; Urano Y; Taniguchi A; Nozaki K; Cronin L; Grauer C; Brueckmann M; Diener HC
    Circ J; 2020 Nov; 84(12):2286-2295. PubMed ID: 33132228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-Case Report of Embolic Stroke of Undetermined Source.
    Li J; Yang XZ; Wang YP; Chen XL; Zhang X
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):e133-e137. PubMed ID: 28476509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Functional Outcome and Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source (ESUS) vs. Cardioembolic Stroke Patients.
    Arauz A; Morelos E; Colín J; Roldán J; Barboza MA
    PLoS One; 2016; 11(11):e0166091. PubMed ID: 27832136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update.
    Hart RG; Catanese L; Perera KS; Ntaios G; Connolly SJ
    Stroke; 2017 Apr; 48(4):867-872. PubMed ID: 28265016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
    Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry.
    Perera KS; Vanassche T; Bosch J; Giruparajah M; Swaminathan B; Mattina KR; Berkowitz SD; Arauz A; O'Donnell MJ; Ameriso SF; Hankey GJ; Yoon BW; Lavallee P; Cunha L; Shamalov N; Brouns R; Gagliardi RJ; Kasner SE; Pieroni A; Vermehren P; Kitagawa K; Wang Y; Muir K; Coutinho J; Vastagh I; Connolly SJ; Hart RG;
    Int J Stroke; 2016 Jul; 11(5):526-33. PubMed ID: 27256472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS).
    Diener HC; Easton JD; Granger CB; Cronin L; Duffy C; Cotton D; Brueckmann M; Sacco RL;
    Int J Stroke; 2015 Dec; 10(8):1309-12. PubMed ID: 26420134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence, characteristics and outcomes in patients with embolic stroke of undetermined source: A population-based study.
    Tsivgoulis G; Kargiotis O; Katsanos AH; Patousi A; Mavridis D; Tsokani S; Pikilidou M; Birbilis T; Mantatzis M; Zompola C; Triantafyllou S; Papanas N; Skendros P; Terzoudi A; Georgiadis GS; Maltezos E; Piperidou C; Tsioufis K; Heliopoulos I; Vadikolias K
    J Neurol Sci; 2019 Jun; 401():5-11. PubMed ID: 30986703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statin treatment and outcomes after embolic stroke of undetermined source.
    Sagris D; Perlepe K; Leventis I; Samara S; Manios E; Korompoki E; Makaritsis K; Milionis H; Vemmos K; Ntaios G
    Intern Emerg Med; 2021 Aug; 16(5):1261-1266. PubMed ID: 33895939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging Risk Factors for Recurrent Vascular Events in Patients With Embolic Stroke of Undetermined Source.
    Ueno Y; Yamashiro K; Tanaka R; Kuroki T; Hira K; Kurita N; Urabe T; Hattori N
    Stroke; 2016 Nov; 47(11):2714-2721. PubMed ID: 27703086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.